Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 19, Issue 1, pp. 312-317
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 4, 2019
- Revision received July 17, 2019
- Accepted September 13, 2019
- Published first September 20, 2019.
Article Versions
- Previous version (September 20, 2019 - 07:42).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Jaume Capdevila1,*,
- Ignacio Matos1,
- Francesco M. Mancuso2,
- Carmela Iglesias3,
- Paolo Nuciforo4,
- Carles Zafon5,
- Hector G. Palmer6,
- Zighereda Ogbah2,
- Laura Muiños2,
- Jorge Hernando1,
- Guillermo Villacampa7,
- Carol E. Peña8,
- Josep Tabernero1,
- Marcia S. Brose9,
- Martin Schlumberger10, and
- Ana Vivancos2
- 1Department of Medical Oncology, Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), Autonomous University of Barcelona (UAB), Barcelona, Spain.
- 2Cancer Genomic Group, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.
- 3Department of Pathology, Vall Hebron University Hospital, Autonomous University of Barcelona (UAB), Barcelona, Spain.
- 4Molecular Oncology Group, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.
- 5Diabetes and Metabolism Research Unit (VHIR) and Department of Endocrinology, Vall Hebron University Hospital and Autonomous University of Barcelona (UAB), Barcelona, Spain.
- 6Stem Cells and Cancer Group, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.
- 7Oncology Data Science Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
- 8Bayer HealthCare Pharmaceuticals Inc., Whippany, New Jersey.
- 9Department of Otorhinolaryngology, Head and Neck Surgery, and Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania.
- 10Gustave Roussy and University Paris Sud, Villejuif, France.
- ↵*Corresponding Author:
Jaume Capdevila, Vall Hebron University Hospital, Pg Vall Hebron 119-129, Barcelona 08035, Spain. Phone: 34-9-3489-4350; Fax: 34-9-3274-6059; E-mail: jacapdevila{at}vhebron.net
January 2020
Volume 19, Issue 1
Volume 19, Issue 1
Identification of Expression Profiles Defining Distinct Prognostic Subsets of Radioactive-Iodine Refractory Differentiated Thyroid Cancer from the DECISION Trial
Jump to section
Advertisement